Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement Therapy in Women with Turner Syndrome
2024-517755-12-00Phase 2Authorised
- Sponsor
- Central Denmark Region
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of testosterone in Turner syndrome (TS), sponsored by Central Denmark Region. Primary endpoint: Changes in body composition. Planned start Apr 2025; status: authorised.
02
Drugs
testosterone
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on 2024-517755-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517755-12-00.